Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.700
0.00 (0.00%)
Oct 28, 2025, 3:48 PM EDT
Veradigm Revenue
In the year 2022, Veradigm had annual revenue of $588.02M with 1.83% growth. Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth.
Revenue
588.02M
Revenue Growth
+1.83%
P/S Ratio
1.36
Revenue / Employee
240.01K
Employees
2,450
Market Cap
798.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 588.02M | 10.59M | 1.83% |
| Dec 31, 2021 | 577.43M | 21.31M | 3.83% |
| Dec 31, 2020 | 556.12M | -1.08B | -65.94% |
| Dec 31, 2019 | 1.63B | 14.77M | 0.91% |
| Dec 31, 2018 | 1.62B | 120.13M | 8.02% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| China New Energy Group Co. | 12.51M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Veradigm News
- 27 days ago - Veradigm Inc. (MDRX) Investor Update Call (Transcript) - Seeking Alpha
- 27 days ago - Veradigm Inc. - Special Call - Seeking Alpha
- 4 weeks ago - Veradigm Inc (MDRX) Q2 2025 Earnings: Revenue Falls Short at $145-$148 Million, Cash Reserves ... - GuruFocus
- 4 weeks ago - Veradigm Provides 2025 Business Update - Business Wire
- 4 weeks ago - DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Veradigm LLC Customers Whose Data May Have Been Compromised - GlobeNewsWire
- 4 weeks ago - Veradigm: A Relisting Special Situation With Strategic Optionality - Seeking Alpha
- 4 weeks ago - Lynch Carpenter Investigates Claims in Veradigm LLC Data Breach - GlobeNewsWire
- 5 weeks ago - Veradigm to Release Business Update September 30th and Host Investor Call October 1st - Business Wire